Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
LTGO Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Other Non-Cash Items history
Currency unavailable · from the cash flow
No Other Non-Cash Items data reported for this period type.
Other Non-Cash Items vs competitors
How LTGO compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $346.87M USD | +16506.2% | — | 1024.4% | |
| LTM Mar 2026 | $23.97M USD | -84.3% | +25.9% | 3.3% | |
| LTM Mar 2026 | $17.44M USD | +10.3% | +44.3% | 2.2% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | +10.3% | +35.1% | 3.3% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.